Neurosense Therapeutics Ltd

Penny Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$0.94

+0.07 (+8.03%)

As of Feb 8, 2:23 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target +3,648.3% upside

Low Target $27.84

Average Target $35.23

High Target $57.14

Current Price $0.94

Current
$0.94

Target
$35.23

$27.84 $35.23 avg $57.14

Scenario Analysis

Bear Case

$27.84

2,862.0%

Low target

Base Case

$35.23

+3,648.3%

Avg target

Bull Case

$57.14

+5,979.4%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$36.15

-97.4% from high

52-Week Low

$25.52

+-96.3% from low

Target vs 52W High

$35.23

-2.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%